Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Varlitinib

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ASLAN's TreeTopp global pivotal study of varlitinib in biliary tract cancer
    ASLAN's TreeTopp global pivotal study of varlitinib in biliary tract cancer

    13 Nov 2019

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=119326&sid=2

    PHARMABIZ
    13 Nov 2019
    Share Share
    Aslan's varlitinib hopes fade after latest failure
    Aslan's varlitinib hopes fade after latest failure

    12 Nov 2019

    // Ben Adams FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/aslan-s-varlitinib-s-hopes-fade-after-latest-failure

    Ben Adams FIERCE BIOTECH
    12 Nov 2019
    Share Share
    Aslan's Presents Late-breaking Data From Ph2 Study In China Testing Varlitinib
    Aslan's Presents Late-breaking Data From Ph2 Study In China Testing Varlitinib

    25 Sep 2019

    // BIOSPACE

    https://www.biospace.com/article/aslan-pharmaceuticals-presents-late-breaking-data-from-phase-2-study-in-china-testing-varlitinib-in-second-line-biliary-tract-cancer-at-csco/?s=95

    BIOSPACE
    25 Sep 2019
    Share Share
    Takeda’s dengue shot; Pfizer’s China Ibrance deal; Aslan job cuts
    Takeda’s dengue shot; Pfizer’s China Ibrance deal; Aslan job cuts

    01 Feb 2019

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma-asia/fiercepharmaasia-takeda-s-dengue-shot-pfizer-s-china-ibrance-deal-aslan-job-cuts

    Angus Liu FIERCE PHARMA
    01 Feb 2019
    Share Share
    Aslan turns focus to biliary tract cancer as lead drug flops in PhII study
    Aslan turns focus to biliary tract cancer as lead drug flops in PhII study

    14 Jan 2019

    // Natalie Grover ENDPTS

    https://endpts.com/aslan-turns-focus-to-biliary-tract-cancer-as-lead-drug-flops-in-phii-study-in-gastric-cancer/

    Natalie Grover ENDPTS
    14 Jan 2019
    Share Share
    ASLAN Pharmaceuticals Completes Recruitment for Phase 2 Study for Varlitinib
    ASLAN Pharmaceuticals Completes Recruitment for Phase 2 Study for Varlitinib

    10 Aug 2018

    // BIOSPACE

    https://www.biospace.com/article/aslan-pharmaceuticals-completes-recruitment-for-global-phase-2-study-for-varlitinib-in-first-line-gastric-cancer/

    BIOSPACE
    10 Aug 2018
    Share Share